Scientists find potential loophole in pancreatic cancer defenses
Dana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control ...
Cancer
Mar 27, 2013 |
5 / 5 (4) |
0
|
Researchers help test cancer drug in clinical trial leading to FDA approval
The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
Cancer
Mar 27, 2013 |
not rated yet |
0
Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
(Medical Xpress)—Individuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine ...
Diabetes
Mar 27, 2013 |
not rated yet |
0
|
Details of gene pathways suggest fine-tuning drugs for child brain tumors
Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists ...
Cancer
Mar 26, 2013 |
not rated yet |
0
|
Scientists examine proton radiography of brain mockup
Los Alamos researchers and German collaborators have investigated the application of giga-electron volt (GeV, or billion electron volts) energy proton beams for medical imaging in combination with proton ...
Medical research
Mar 26, 2013 |
not rated yet |
0
Higher soy intake prior to lung cancer diagnosis linked to longer survival in women
New results from a large observational follow-up study conducted in Shanghai, China, indicate that women with lung cancer who consumed more soy food prior to their cancer diagnosis lived longer than those who consumed less ...
Cancer
Mar 25, 2013 |
not rated yet |
0
Monoclonal antibody targets, kills leukemia cells
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.
Cancer
Mar 25, 2013 |
5 / 5 (4) |
0
|
Kidney sparing surgery underutilized for patients who need it most
Researchers at the University of California, San Diego School of Medicine have released study results that show national treatment trends in the surgical management of patients with kidney disease. The study found that partial ...
Surgery
Mar 25, 2013 |
not rated yet |
0
Storming the gates: Study probes how pancreatic cancers metastasize
Researchers at the University of North Carolina at Chapel Hill have discovered that a protein found in the cells surrounding pancreatic cancers play a role in the spread of the disease to other parts of the ...
Cancer
Mar 25, 2013 |
not rated yet |
0
|
Detecting circulating tumor cells
A proof-of-concept device is nearly perfect in separating breast cancer cells from blood.
Cancer
Mar 25, 2013 |
not rated yet |
0
Men and women get sick in different ways
At the dawn of third millennium medical researchers still know very little about gender-specific differences in illness, particularly when it comes to disease symptoms, influencing social and psychological factors, and the ...
Cardiology
Mar 22, 2013 |
4 / 5 (1) |
1
Functional characteristics of antitumor T cells change w increasing time after therapeutic transfer
Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time. The data, which are published in Cancer Discovery, a journal of the ...
Cancer
Mar 21, 2013 |
not rated yet |
0
'Toxicity map' of brain may help protect cognition for cancer patients
New research from Wake Forest Baptist Medical Center is giving radiation oncologists who treat brain tumors a better understanding of how to preserve the brain's functions while still killing cancer.
Cancer
Mar 20, 2013 |
4 / 5 (2) |
0
Immortality gene mutation identifies brain tumors, other cancers
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research ...
Cancer
Mar 18, 2013 |
5 / 5 (3) |
0
|
How some prostate tumors resist treatment—and how it might be fixed
Hormonal therapies can help control advanced prostate cancer for a time. However, for most men, at some point their prostate cancer eventually stops responding to further hormonal treatment. This stage of ...
Cancer
Mar 18, 2013 |
5 / 5 (2) |
0
|
